Twitter
Advertisement

Novartis India completes animal health business sale transaction

Swiss drug major Novartis had closed the transfer of the animal health business to US-based Eli Lilly globally in January last year.

Latest News
article-main
FacebookTwitterWhatsappLinkedin

Drug firm Novartis India has completed the transaction to sell its animal health business to Elanco India, an affiliate of Eli Lilly.

"Following the approval from the Foreign Investment Promotion Board (FIPB), Indian government and Competition Commission of India (CCI), we wish to inform you that the transaction for the transfer of the company's animal health division to Elanco India has been completed," Novartis India said in a BSE filing on Friday. 

Swiss drug major Novartis had closed the transfer of the animal health business to US-based Eli Lilly globally in January last year.

In April 2014, Novartis had agreed to sell its global animal health business to Eli Lilly and Co for about  $5.4 billion (nearly Rs 35,872.2 crore) in an all-cash transaction.

On Friday, at 13:36 hours, the shares of Novartis India were trading down at 0.22% or Rs 1.75 at Rs 807.25 per scrip intraday on BSE.  

 
Find your daily dose of news & explainers in your WhatsApp. Stay updated, Stay informed-  Follow DNA on WhatsApp.
Advertisement

Live tv

Advertisement
Advertisement